Characterization of arginase expression by equine neutrophils

Vet Immunol Immunopathol. 2014 Feb 15;157(3-4):206-13. doi: 10.1016/j.vetimm.2013.12.007. Epub 2013 Dec 30.

Abstract

Neutrophils are the predominant cells recruited in the airways of horses suffering from heaves. These cells have been shown to express arginase in some species. The metabolism of l-arginine is thought to be involved in chronic inflammation, and airway obstruction and remodeling. The aim of this study was to assess the expression, regulation, activity, and functional role of arginase isoforms in equine neutrophils. Arginase I, arginase II, ornithine decarboxylase (ODC) and ornithine aminotransferase (OAT) expression were assessed in resting and stimulated (IL-4, LPS/fMLP, PMA; 5 and 18 h) blood neutrophils using quantitative PCR. Arginase expression was also studied by Western blot and enzyme activity assay. The effect of nor-NOHA (1mM), a specific arginase inhibitor, was assessed on arginase activity in vitro and ex vivo on neutrophil's inflammatory gene expression and viability. Results showed that equine neutrophils constitutively express arginase isoform 2, ODC and OAT. Neutrophil ex vivo stimulation did not induce arginase I or influence arginase II mRNA expression. Ex vivo inhibition of arginase activity by nor-NOHA had no effect on neutrophils inflammatory gene expression induced by LPS/fMLP (5h) but significantly reversed the cell loss observed after this stimulation.

Keywords: Apoptosis; Arginase; Heaves; Neutrophil; Pro-inflammatory cytokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / antagonists & inhibitors
  • Arginase / genetics
  • Arginase / physiology*
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Cells, Cultured
  • Female
  • Horses / immunology*
  • Humans
  • Lipopolysaccharides / pharmacology
  • Neutrophils / enzymology*

Substances

  • Lipopolysaccharides
  • N(omega)-hydroxynorarginine
  • Arginine
  • Arginase